SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-025641
Filing Date
2020-05-15
Accepted
2020-05-15 08:00:29
Documents
5
Period of Report
2020-06-24
Effectiveness Date
2020-05-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A odt-def14a_20200624.htm DEF 14A 1208320
2 GRAPHIC gzynpatsgg45000001.jpg GRAPHIC 6916
3 GRAPHIC gzynpatsgg45000004.jpg GRAPHIC 56153
4 GRAPHIC gzynpatsgg45000002.jpg GRAPHIC 6916
5 GRAPHIC gzynpatsgg45000003.jpg GRAPHIC 70520
  Complete submission text file 0001564590-20-025641.txt   1403672
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38318 | Film No.: 20880649
SIC: 2834 Pharmaceutical Preparations